About FDA

Percentage of INAD study submissions reviewed within the month that were acted on within 180 days after the submission date

Dictionary: Sponsors may submit data intended to support an application for new animal drug approval during the investigation of the new animal drug to an INAD file. A study submission is a submission containing both the data and conclusions of a study to be considered in support of the approval of a new animal drug. This measure assesses ONADE's timely review and decision making on one aspect of a new animal drug application. (1)

Information is current as of February 28, 2013.

• FY 2010
• FY 2011
• FY 2012
• FY 2013
• All

Footnotes

• (1) This metric is also an Animal Drug User Fee Program performance goal. In the yearly performance report to Congress, performance is reported for a defined fiscal year receipt cohort. The methodology for reporting by fiscal year receipt cohort calculates performance statistics for submissions for the fiscal year FDA received them, regardless of when FDA ultimately acted on or approved the submissions. The data reported here is the measurement of the number of applications reviewed in a given month regardless of the cohort year.

Number of INAD study submissions reviewed within the month that were acted upon within 180 days after the submission date

Fiscal Year - 2012

Time	Target	Number
Oct 2011	N/A	11
Nov 2011	N/A	9
Dec 2011	N/A	12
Jan 2012	N/A	12
Feb 2012	N/A	22
Mar 2012	N/A	36
Apr 2012	N/A	25
May 2012	N/A	15
Jun 2012	N/A	25
Jul 2012	N/A	17
Aug 2012	N/A	20
Sep 2012	N/A	27

FY 2012 Total: 231

Number of INAD study submissions reviewed and acted on within the month

Fiscal Year - 2012

Time	Target	Number
Oct 2011	N/A	11
Nov 2011	N/A	9
Dec 2011	N/A	12
Jan 2012	N/A	12
Feb 2012	N/A	22
Mar 2012	N/A	36
Apr 2012	N/A	25
May 2012	N/A	15
Jun 2012	N/A	25
Jul 2012	N/A	17
Aug 2012	N/A	20
Sep 2012	N/A	27

FY 2012 Total: 231